These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 22939190)

  • 1. Modulation of HIV reservoirs by host HLA: bridging the gap between vaccine and cure.
    Brumme ZL; Chopera DR; Brockman MA
    Curr Opin Virol; 2012 Oct; 2(5):599-605. PubMed ID: 22939190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and evolutionary consequences of HIV adaptation to HLA: implications for vaccine and cure.
    Avila-Rios S; Carlson JM; John M; Mallal S; Brumme ZL
    Curr Opin HIV AIDS; 2019 May; 14(3):194-204. PubMed ID: 30925534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HIV-1 adaptation to HLA: a window into virus-host immune interactions.
    Carlson JM; Le AQ; Shahid A; Brumme ZL
    Trends Microbiol; 2015 Apr; 23(4):212-24. PubMed ID: 25613992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune control of HIV-1 reservoirs.
    Autran B; Descours B; Bacchus C
    Curr Opin HIV AIDS; 2013 May; 8(3):204-10. PubMed ID: 23493099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HIV vaccines: where we are and where we are going.
    Haynes BF
    Lancet; 1996 Oct; 348(9032):933-7. PubMed ID: 8843815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cure of HIV infection: is the long wait over?
    Shearer WT
    J Allergy Clin Immunol; 2014 Jul; 134(1):20-2. PubMed ID: 25117800
    [No Abstract]   [Full Text] [Related]  

  • 7. New research in HIV immunity points way for vaccine.
    Rees J
    Expert Rev Clin Immunol; 2013 May; 9(5):403. PubMed ID: 23772447
    [No Abstract]   [Full Text] [Related]  

  • 8. Challenges in the development of an HIV-1 vaccine.
    Barouch DH
    Nature; 2008 Oct; 455(7213):613-9. PubMed ID: 18833271
    [TBL] [Abstract][Full Text] [Related]  

  • 9. HIV evolution in response to HLA-restricted CTL selection pressures: a population-based perspective.
    Carlson JM; Brumme ZL
    Microbes Infect; 2008 Apr; 10(5):455-61. PubMed ID: 18407775
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Eradication of HIV-1 latent reservoirs through therapeutic vaccination.
    Pankrac J; Klein K; Mann JFS
    AIDS Res Ther; 2017 Sep; 14(1):45. PubMed ID: 28893280
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sequence analysis of HIV-1 isolates from Guinea-Bissau: selection of vaccine epitopes relevant in both West African and European countries.
    Vinner L; Holmgren B; Jensen KJ; Esbjornsson J; Borggren M; Hentze JL; Karlsson I; Andresen BS; Gram GJ; Kloverpris H; Aaby P; Da Silva ZJ; Fenyö EM; Fomsgaard A
    APMIS; 2011 Aug; 119(8):487-97. PubMed ID: 21749448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV-1 reservoirs in elite controllers: clues for developing a functional cure?
    May ME; Kwaa AK; Blankson JN
    Future Microbiol; 2017 Sep; 12():1019-1022. PubMed ID: 28836451
    [No Abstract]   [Full Text] [Related]  

  • 13. Potential vaccination strategy focuses on reactivating latent HIV.
    Patience J
    Expert Rev Anti Infect Ther; 2012 May; 10(5):526. PubMed ID: 22702324
    [No Abstract]   [Full Text] [Related]  

  • 14. New research in HIV immunity points way for vaccine.
    Rees J
    Immunotherapy; 2013 May; 5(5):445-6. PubMed ID: 23638739
    [No Abstract]   [Full Text] [Related]  

  • 15. Toward T Cell-Mediated Control or Elimination of HIV Reservoirs: Lessons From Cancer Immunology.
    Mylvaganam G; Yanez AG; Maus M; Walker BD
    Front Immunol; 2019; 10():2109. PubMed ID: 31552045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Emerging Role for CTL Epitope Specificity in HIV Cure Efforts.
    Kaseke C; Tano-Menka R; Senjobe F; Gaiha GD
    J Infect Dis; 2021 Feb; 223(12 Suppl 2):32-37. PubMed ID: 33586771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Crosscurrents in HIV-1 evolution.
    Blankson JN; Bailey JR; Siliciano RF
    Nat Immunol; 2006 Feb; 7(2):121-2. PubMed ID: 16424885
    [No Abstract]   [Full Text] [Related]  

  • 18. Progress and obstacles in the development of an AIDS vaccine.
    Letvin NL
    Nat Rev Immunol; 2006 Dec; 6(12):930-9. PubMed ID: 17124514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level.
    Moore CB; John M; James IR; Christiansen FT; Witt CS; Mallal SA
    Science; 2002 May; 296(5572):1439-43. PubMed ID: 12029127
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Protective mucosal immunity and HIV-1 mucosal vaccine strategy].
    Huang Y; Huang XG; Xu JQ
    Bing Du Xue Bao; 2009 Jul; 25(4):318-22. PubMed ID: 19769168
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.